alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    Exhibit 10-6

                  DESCRIPTION OF 2002 COMPENSATION ARRANGEMENTS
                          WITH LUBIN, DELANO & COMPANY

         During 2002, Lexington Precision Corporation (the "Company")
compensated Michael A. Lubin, its Chairman of the Board, and Warren Delano, its
President, indirectly through payments to Lubin, Delano & Company, an investment
banking firm of which they are the only partners. These compensation
arrangements provided for payment to Lubin, Delano & Company of a basic fee of
$500,000, and provided for a possible incentive fee based upon attaining an
operating profit target for the Company and possible transaction fees as might
be agreed upon by the Company and Lubin, Delano & Company in connection with
acquisitions, divestitures, financings and other similar transactions.
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2410 Culture medium for pathogenic *Neisseria* spp. ( a ) *Identification.* A culture medium for pathogenic *Neisseria* spp. is a device that consists primarily of liquid or solid biological materials used to cultivate and identify pathogenic *Neisseria* spp. The identification aids in the diagnosis of disease caused by bacteria belonging to the genus *Neisseria,* such as epidemic cerebrospinal meningitis, other meningococcal disease, and gonorrhea, and also provides epidemiological information on these microorganisms.
( b ) *Classification.* Class II (performance standards).
EXHIBIT 35.1



World Omni Financial Corp.

Servicer Compliance Statement

Pursuant to Item 1123

of Regulation AB



I, William J. Shope,
do hereby certify that I am the Group Vice President and Chief Financial Officer of World Omni Financial Corp., a Florida corporation,
and further certify on behalf of World Omni Financial Corp. in its capacity as servicer (the “Servicer”) under the
Exchange Note Servicing Supplement 2015-A to Closed-End Servicing Agreement, dated as of July 29, 2015 (the “Exchange Note
Servicing Supplement”), among AL Holding Corp., as Closed-End Collateral Agent, World Omni LT, as Titling Trust, and the
Servicer, as follows:



(i)         A
review of the activities of the Servicer during the period covered by the issuing entity’s Annual Report on form 10-K and
covered by the Exchange Note Servicing Supplement and the Closed-End Servicing Agreement (as defined in the Exchange Note Servicing
Supplement) for the fiscal year ended December 31, 2017 (the “Reporting Period”), and of its performance under the
Exchange Note Servicing Supplement and the Closed-End Servicing Agreement (as defined in the Exchange Note Servicing Supplement),
has been made under my supervision.



(ii)         To
the best of my knowledge, based on the review described above, the Servicer has fulfilled all of its obligations under the Exchange
Note Servicing Supplement and the Closed-End Servicing Agreement (as defined in the Exchange Note Servicing Supplement) in all
material respects throughout the Reporting Period.



IN WITNESS WHEREOF, I have hereunto
set my hand as of March 9, 2018.



| | WORLD OMNI FINANCIAL CORP.
| | --------------------------
| |                           
| | By:                       



| | Name:  | William J. Shope       
| | ------ | -----------------------
| | Title: | Group Vice President & 
| |        | Chief Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. 

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Institute of Nursing Research Special Emphasis Panel, Predoctoral Individual National Research Service Award.                     

*Date:*                         February 19, 2010.                     

*Time:*                         1 p.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                     

*Contact Person:*                         Weiqun Li, MD, Scientific Review Administrator, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Blvd., Ste. 710, Bethesda, MD 20892, (301) 594-5966,                         *wli@mail.nih.gov.*      ( print page 1795)    

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS)

Dated: January 6, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-428 Filed 1-12-10; 8:45 am] 

BILLING CODE 4140-01-P
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.4475 Surgical vessel dilator. ( a ) *Identification.* A surgical vessel dilator is a device used to enlarge or calibrate a vessel.
( b ) *Classification.* Class II (performance standards).
**Exhibit32.1**

**CERTIFICATIONPURSUANT TO****18 U.S.C. SECTION 1350,****AS ADOPTED PURSUANT TO****SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with theQuarterly Report on Form 10-Q of Ebix, Inc. (the “Company”) for the periodended June 30, 2007 as filed with the Securities and Exchange Commission on thedate hereof (the “Report”), I, Robin Raina, Chief Executive Officer of theCompany, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of theSarbanes-Oxley Act of 2002, that:

1. The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

2. The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.
| By:                     | /s/ Robin Raina |   |   |   |
|-------------------------|-----------------|--------|--------|--------|
|                    |            |   |   |   |
| Name:                   | Robin Raina     |   |   |   |
|                    |            |   |   |   |
| Chief Executive Officer |            |   |   |   |
|                    |            |   |   |   |
| August 10, 2007         |            |   |   |   |
|                         |                 |        |        |        |  |  |

 

 

----
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED> 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           2,707
<SECURITIES>                                     6,703
<RECEIVABLES>                                    3,797
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,419
<PP&E>                                           7,818
<DEPRECIATION>                                   5,907
<TOTAL-ASSETS>                                  23,694
<CURRENT-LIABILITIES>                            6,866
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            51
<OTHER-SE>                                      16,666
<TOTAL-LIABILITY-AND-EQUITY>                    23,694
<SALES>                                          3,158
<TOTAL-REVENUES>                                 5,805
<CGS>                                              611
<TOTAL-COSTS>                                    1,523
<OTHER-EXPENSES>                                 4,094
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    325
<INCOME-TAX>                                       120
<INCOME-CONTINUING>                                205
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       205
<EPS-PRIMARY>                                      .04
<EPS-DILUTED>                                      .04
        

</TABLE>
§ 807.40 Establishment registration and device listing for foreign establishments importing or offering for import devices into the United States. ( a ) Any establishment within any foreign country engaged in the manufacture, preparation, propagation, compounding, or processing of a device that is imported or offered for import into the United States shall register such establishment and list such devices using the FDA electronic device registration and listing system in conformance with the procedures in this section, § 807.41, and subpart B of this part. The official correspondent for the foreign establishment shall facilitate communication between the foreign establishment's management and representatives of FDA for matters relating to the registration of device establishments and the listing of device products.
( b ) Each foreign establishment required to register under paragraph (a) of this section shall submit the name, address, and phone number of its United States agent as part of its initial and updated registration information in accordance with subpart B of this part. Each foreign establishment shall designate only one United States agent and may designate the United States agent to act as its official correspondent. ( 1 ) The United States agent shall reside or maintain a place of business in the United States.
( 2 ) Upon request from FDA, the United States agent shall assist FDA in communications with the foreign establishment, respond to questions concerning the foreign establishment's products that are imported or offered for import into the United States, and assist FDA in scheduling inspections of the foreign establishment. If the agency is unable to contact the foreign establishment directly or expeditiously, FDA may provide information or documents to the United States agent, and such an action shall be considered to be equivalent to providing the same information or documents to the foreign establishment.
( 3 ) The foreign establishment or the United States agent shall report changes in the United States agent's name, address, or phone number to FDA within 10-business days of the change.
( c ) No device may be imported or offered for import into the United States unless it is the subject of a device listing as required under subpart B of this part and is manufactured, prepared, propagated, compounded, or processed at a registered foreign establishment; however, this restriction does not apply to devices imported or offered for import under the investigational use provisions of part 812 of this chapter.
( d ) The device establishment registration and device listing information shall be in the English language.
[66 FR 59160, Nov. 27, 2001, as amended at 77 FR 45944, Aug. 2, 2012]
COURT OF APPEALS

	SECOND DISTRICT OF TEXAS

	FORT WORTH

					NO. 2-07-153-CR

DWAYNE THOMAS SEERY		       					APPELLANT

	V.

THE STATE OF TEXAS	STATE

	----------

	FROM THE 371ST DISTRICT COURT OF TARRANT COUNTY

	----------

	MEMORANDUM OPINION1 AND JUDGMENT

						----------

	We have considered the “Appellant’s Motion To Dismiss Appeal.”  The motion complies with rule 42.2(a) of the rules of appellate procedure. Tex. R. App. P. 42.2(a).  No decision of this court having been delivered before we received this motion, we grant the motion and dismiss the appeal. See  Tex. R. App. P. 42.2(a), 43.2(f). 							 										PER CURIAM

PANEL D:	GARDNER, WALKER, and MCCOY, JJ.

DO NOT PUBLISH

Tex. R. App. P. 47.2(b)

DELIVERED: March 6, 2008
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) DAY
INTERNATIONAL GROUP, INC.'S ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED
DECEMBER 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH (B) FORM
10K
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                             780
<SECURITIES>                                         0
<RECEIVABLES>                                   22,648
<ALLOWANCES>                                     1,055
<INVENTORY>                                     16,501
<CURRENT-ASSETS>                                42,648
<PP&E>                                          56,386
<DEPRECIATION>                                (11,594)
<TOTAL-ASSETS>                                 225,527
<CURRENT-LIABILITIES>                           23,019
<BONDS>                                        130,109
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                      60,188
<TOTAL-LIABILITY-AND-EQUITY>                   225,527
<SALES>                                        166,286
<TOTAL-REVENUES>                               166,286
<CGS>                                          103,035
<TOTAL-COSTS>                                  135,875
<OTHER-EXPENSES>                                   629
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,926
<INCOME-PRETAX>                                 13,856
<INCOME-TAX>                                     5,939
<INCOME-CONTINUING>                              7,917
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,917
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Legal sponsor: City of Klamath Falls, OR 

DUNS: 01-074-3300 

Tax ID: 93-6002195 

Congressional 

 District: OR 02 

Contact: John Longley

City of Klamath Falls, OR 

Airport Director 

6775 Arnold Avenue 

Klamath Falls, OR 97603 

Phone: (541) 883-5372 

Email: jlongley@flykfalls.com 

Docket #: DOT-OST-2011-0119 

Date: August 2, 2011 

Proposal Under 

the Small 

Community Air 

Service 

Development 

Program
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Consolidated  Balance Sheets  (Unaudited) as of January 30, 2000 and October 31,
1999 and the Consolidated  Statements of Operations (Unaudited) for the quarters
ended January 30, 2000 and January 31, 1999.

</LEGEND>
<CIK>                         0000814249
<NAME>                        MICROAGE INC
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. DOLLARS


<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              OCT-31-1999
<PERIOD-START>                                 NOV-01-1999
<PERIOD-END>                                   JAN-01-1999
<EXCHANGE-RATE>                                          1
<CASH>                                              31,818
<SECURITIES>                                             0
<RECEIVABLES>                                      450,236
<ALLOWANCES>                                        37,929
<INVENTORY>                                        245,240
<CURRENT-ASSETS>                                   714,191
<PP&E>                                             228,603
<DEPRECIATION>                                     133,014
<TOTAL-ASSETS>                                     846,987
<CURRENT-LIABILITIES>                              641,723
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                               208
<OTHER-SE>                                         102,505
<TOTAL-LIABILITY-AND-EQUITY>                       846,987
<SALES>                                          1,112,881
<TOTAL-REVENUES>                                 1,112,881
<CGS>                                            1,063,315
<TOTAL-COSTS>                                    1,063,315
<OTHER-EXPENSES>                                    13,985
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                     963
<INCOME-PRETAX>                                    (48,346)
<INCOME-TAX>                                       (18,093)
<INCOME-CONTINUING>                                (30,253)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       (30,253)
<EPS-BASIC>                                          (1.45)
<EPS-DILUTED>                                        (1.45)


</TABLE>
EXHIBIT 12(A)

                     PUBLIC SERVICE ELECTRIC AND GAS COMPANY
                COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                            PLUS PREFERRED SECURITIES
                                   (Millions)

                                                       -------------------------
                                                          For the Nine Months
                                                          Ended September 30,
                                                       -------------------------
                                                          2002          2001
                                                       -----------   -----------

Earnings as Defined in Regulation S-K (A):

Pre-tax Income from Continuing Operations                $   204       $   292
Fixed Charges                                                322           377
Preferred Securities Dividend Requirements                   (10)          (22)
Preferred Stock Dividends - PreTax                            (5)           (7)
Capitalized Interest                                          (1)           (2)
                                                         -------       -------
Earnings                                                 $   510       $   638
                                                         =======       =======

Fixed Charges as Defined in
Regulation S-K (B):

Interest Expense                                         $   307       $   346
Interest Factor in Rentals                                     0             2
Preferred Securities Dividend Requirements                    10            22
Preferred Stock Dividends - (Gross Up for Tax)                 3             4
Adjustment to Preferred Stock Dividend Requirement             2             3
                                                         -------       -------
Total Fixed Charges                                      $   322       $   377
                                                         =======       =======

Ratio of Earnings to Fixed Charges                          1.58          1.69
                                                         =======       =======

(A)   The term  "earnings"  shall be defined as pretax  income  from  continuing
      operations.  Add to pretax income the amount of fixed charges  adjusted to
      exclude the amount of any interest capitalized during the period.

(B)   Fixed Charges represent (a) interest, whether expensed or capitalized, (b)
      amortization of debt discount,  premium and expense and (c) an estimate of
      interest implicit in rentals.
EXHIBIT 32.1

CERTIFICATION

I, Brian F. Lavin, President of NTS
Capital Corporation, the general partner of NTS-Properties Associates VII, the general partner
of NTS-Properties VII, Ltd. (the Partnership), certify, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

|1. |  | The quarterly report on Form 10-Q of the Partnership for the period ended March
               31, 2004 (the Report) fully complies with the requirements of
               Section 13(a) of the Securities Exchange Act of 1934, as amended; and
|-- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. |  | The information contained in the Report fairly presents, in all material
               respects, the financial condition and results of operations of the Partnership.
|-- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Dated: May 13, 2004

/s/ Brian F. Lavin

---

President of NTS Capital Corporation,
General Partner of NTS-Properties Associates VII,
General Partner of NTS-Properties VII, Ltd.

A signed original of this written
statement required by Section 906 has been provided to the Partnership and will be
retained by the Partnership and furnished to the Securities and Exchange Commission or its
staff upon request.